← Back to Search

COMPAS Participants for Surgery (COMPAS Trial)

N/A
Waitlist Available
Led By Michael Bullock, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
aged 18-90 years old who are undergoing elective orthopedic surgery at Duke Health.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

COMPAS Trial Summary

This trial is testing whether a new way of measuring pain can help predict which patients are at high risk for chronic opioid use.

Who is the study for?
This trial is for English-reading adults aged 18-90 who are scheduled for elective orthopedic surgery at Duke Health and own a smartphone. It aims to identify those at risk of chronic opioid use after surgery.Check my eligibility
What is being tested?
The COMPAS Participants study measures pain, psychosocial outcomes, functionality, and actual opioid usage post-surgery to predict the risk of long-term opioid use in patients.See study design

COMPAS Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 90 years old and will have elective orthopedic surgery at Duke Health.

COMPAS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid Use of Participants
Practicality of Mobile Application
Reported Pain of Participants measured via PROMIS-29
+1 more

COMPAS Trial Design

1Treatment groups
Experimental Treatment
Group I: COMPAS ParticipantsExperimental Treatment1 Intervention
Patents between the ages of 18 and 90 who are undergoing orthopedic surgery at Duke Health will be eligible for enrollment.

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,359 Previous Clinical Trials
3,410,222 Total Patients Enrolled
5 Trials studying Surgery
474 Patients Enrolled for Surgery
Michael Bullock, MDPrincipal InvestigatorDuke University
Neil D Ray, MDPrincipal Investigatorneil.d.ray@duke.edu

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6667 spots leftby Apr 2025